clinical trial · NCT06757257
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Kissei Pharmaceutical Co., Ltd.·—·recruiting·n = 149
Chronic Idiopathic Thrombocytopenic Purpurafostamatinib
brief summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
started
May 29, 2023
primary completion
Sep 30, 2028
completion
Sep 30, 2028
last updated
Jan 3, 2025
detailed description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol